Company: PIII
Filing Date: 2025-03-03
Form Type: DEF 14A
Source: 0001140361-25-006787
Chunk: 3

Company: P3 Health Partners Inc.
Filing Date: 2025-03-03
Form: DEF 14A
Chunk 3
---
”) for use at the Special Meeting of Stockholders (“Special Meeting”) to be held on Monday, March 31, 2025, beginning at 9:00 a.m., Pacific time, and at any continuation, postponement or adjournment of the Special Meeting.

The Special Meeting will be a completely virtual meeting, conducted via live webcast. You will be able to attend the Special Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/PIII2025SM and entering your 16-digit control number included on your proxy card. On or about March 3, 2025 we are releasing this proxy statement and accompanying proxy materials to our stockholders of record on the record date for the meeting.**

### IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
<div align='center'>**FOR THE STOCKHOLDER MEETING TO BE HELD ON MARCH 31, 2025

THIS PROXY STATEMENT IS ALSO AVAILABLE ONLINE AT WWW.PROXYVOTE.COM.

1**</div>

#### TABLE OF CONTENTS

### INFORMATION ABOUT THIS PROXY STATEMENT
Why you received this proxy statement . You have received these proxy materials because the Company’s Board is soliciting your proxy to vote your shares at the Special Meeting. This proxy statement includes information that we are required to provide to you under the rules of the Securities and Exchange Commission (“SEC”) and that is designed to assist you in voting your shares.

<div align='center'>2</div>

TABLE OF CONTENTS

INFORMATION ABOUT THE SPECIAL MEETING AND VOTING What is the purpose of the Special Meeting? At our Special Meeting, stockholders will act upon the matters outlined in the accompanying notice of meeting, including:

| (1) | the approval of amendments to our amended and restated certificate of incorporation (our “Certificate of Incorporation”) to effect a reverse stock split of our Class A common stock, $0.0001 par value per share, and Class V common stock, $0.0001 par value per share (collectively, the “common stock”) at a ratio ranging from any whole number between 1-for-10 and 1-for-60, as determined by our Board in its discretion, subject to the Board’s authority to abandon such amendments (“Proposal 1” or the “Reverse Stock Split proposal”); and |

| (2) | the approval of the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not